ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.037,59
1,06%
Dow Jones
43.325,80
0,07%
Euro vs US Dollar
1,04203
0,21%
Bitcoin
95.670,50
-3,66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. F star Therapeutics Inc (FSTX) Börsenkurse

F star Therapeutics Inc

F star Therapeutics Inc (FSTX)

NASDAQ
7,12
0,00
(0,00%)
Beim Schlusskurs: 26 Dezember 10:00PM
Verzögert um 15 Minuten
7,12
0,00
( 0,00% )
Nach Börsenschluss: -
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
7,12
Gebot
7,20
Fragen
7,72
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
7,12
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

FSTX Neueste Nachrichten

Weitere Nachrichten

F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3

Provides U.S. Patent Protection to at least August 2038 Expands Patent Protection for FS118 Composition of Matter beyond Europe CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 20, 2022...

20 Januar 2022
GlobeNewswire Inc.

F-star Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

07 Januar 2022
GlobeNewswire Inc.

F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

05 Januar 2022
GlobeNewswire Inc.

F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

07 Dezember 2021
GlobeNewswire Inc.

F-star Therapeutics to Host Virtual R&D Day on December 6, 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

29 November 2021
GlobeNewswire Inc.

F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference

Dr. Michelle Morrow to present on F-star’s Proprietary Bispecific Platform including FS118, our LAG-3/PD-L1 Bispecific Poster Presentation of Preclinical Data Demonstrates Potential for F-star’s...

12 November 2021
GlobeNewswire Inc.

F-star Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Company to Host Conference Call Today at 9 a.m. EST CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) --  F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage...

10 November 2021
GlobeNewswire Inc.

F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

01 November 2021
GlobeNewswire Inc.

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Ltd. (NASDAQ: FSTX) (“F-star” or the “Company”), a clinical-stage biopharmaceutical company...

20 Oktober 2021
GlobeNewswire Inc.

F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

16 September 2021
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FSTX - Frequently Asked Questions (FAQ)

What is the current F star Therapeutics share price?
The current share price of F star Therapeutics is US$ 7,12
What is the 1 year trading range for F star Therapeutics share price?
F star Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EVAXEvaxion Biotech AS
US$ 1,76
(107,91%)
2,68M
OMEXOdyssey Marine Exploration Inc
US$ 0,7085
(47,45%)
3,94M
PWMPrestige Wealth Inc
US$ 1,68
(20,86%)
84,11k
SNAXStryve Foods Inc
US$ 0,7822
(18,14%)
856,59k
LNZALanzaTech Global Inc
US$ 2,26
(9,98%)
12,14k
BCGBinah Capital Group Inc
US$ 2,72
(-15,00%)
12,28k
MRNSMarinus Pharmaceuticals Inc
US$ 0,2826
(-12,45%)
54,17k
BDRXBiodexa Pharmaceuticals PLC
US$ 4,20
(-11,21%)
550
XELBXcel Brands Inc
US$ 0,46
(-10,07%)
13,53k
MSSMaison Solutions Inc
US$ 1,09
(-8,40%)
1,53k
OMEXOdyssey Marine Exploration Inc
US$ 0,7085
(47,45%)
3,94M
EVAXEvaxion Biotech AS
US$ 1,76
(107,91%)
2,68M
RGTIRigetti Computing Inc
US$ 15,70
(1,65%)
1,87M
ADTXAditxt Inc
US$ 0,19
(-0,78%)
1,69M
SOFISoFi Technologies Inc
US$ 16,5697
(-0,17%)
1,45M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
FSTX
F star Therapeutics
AQSE
JHD.GB
James Halstead
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten